Gall Bladder Cancer
A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)
- Details
ClinicalTrials.gov ID:
NCT05506943
Diagnosis Type:
NA
USOR Number:
- Address
5125 Texoma Medical Center Dr.
Suite 100
Denison, TX 75020
P: 903-868-4700